Most cited papers from Xenikos (Netherlands)
What are the most cited papers from Xenikos (Netherlands)?
The most cited paper from Xenikos (Netherlands) is "Phase I/II Trial of a Combination of Anti-CD3/CD7 Immunotoxins for Steroid-Refractory Acute Graft-versus-Host Disease" (Christoph Groth, Lenneke F. J. van Groningen, Tiago R. Matos et al., 2018), with 34 citations. Next come "Lessons learned from early closure of a clinical trial for steroid-refractory acute GVHD" (5) and "Does using a foreign language reduce mental imagery?" (4).
Showing 6 of 6 papers. Every paper is listed.
| # | Paper | ||
|---|---|---|---|
| 1 | Phase I/II Trial of a Combination of Anti-CD3/CD7 Immunotoxins for Steroid-Refractory Acute Graft-versus-Host Disease Christoph Groth, Lenneke F. J. van Groningen, Tiago R. Matos et al. · Transplantation and Cellular Therapy | 3 Nov 2018 | 34 |
| 2 | Lessons learned from early closure of a clinical trial for steroid-refractory acute GVHD Gabrielle Meyers, Mehdi Hamadani, Michael J. Martens et al. · Bone Marrow Transplantation | 23 Nov 2021 | 5 |
| 3 | Does using a foreign language reduce mental imagery? Guillermo Montero‐Melis, Petrus Isaksson, Jeroen van Paridon et al. | 19 Sep 2019 | 4 |
| 4 | Anti-CD3/CD7 immunoconjugate (T-Guard) for severe, steroid-refractory GVHD: final report of BMT CTN 2002 Gabrielle Meyers et al. · Bone Marrow Transplantation | 25 Sep 2023 | 3 |
| 5 | A Phase I/II Study on the Anti-CD3/CD7 Immunotoxin Combination (T-GuardTM) for the Treatment of Steroid-Refractory Acute Gvhd Christoph Groth, Lenneke F. J. van Groningen, Manita E. J. Bremmers et al. · Blood | 7 Dec 2017 | 1 |
| 6 | 088 A phase I/II study on the anti-CD3/CD7 immunotoxin combination for the treatment of steroid-refractory acute GVHD T. Matos, Frank W. M. B. Preijers, L.F. van Groningen et al. · Journal of Investigative Dermatology | Sep 2019 | 0 |
Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.